New Abuse-Deterrent Extended-Release Oxycodone Approved by FDA
July 24, 2014 at 06:10:00 ET
The U.S. Food and Drug Administration on July 23 approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic, to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The FDA said Targiniq ER ... Read More
